Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of salivary hemoglobin measurements for periodontitis screening.
Okada A, Nomura Y, Sogabe K, Oku H, Sato Gillbreath A, Hino F, Hayashi H, Yoshino H, Utsunomiya H, Suzuki K, Koresawa K, Koba K, Uetani K, Kotoh M, Nishitsuji N, Akutsu S, Nakasone T, Tobi Y, Fukuzawa Y, Yabuki Y, Naono Y, Yajima M, Shimizu K, Hanada N. Okada A, et al. Among authors: yabuki y. J Oral Sci. 2017;59(1):63-69. doi: 10.2334/josnusd.16-0204. J Oral Sci. 2017. PMID: 28367900 Free article.
PRECEDE-PROCEED model based questionnaire and saliva tests for oral health checkup in adult.
Nomura Y, Matsuyama T, Fukai K, Okada A, Ida M, Yamauchi N, Hanamura H, Yabuki Y, Watanabe K, Sugawara M, Imanishi Y, Koizumi N, Murano Y, Nishiyama A, Fukukawa Y, Otsuka R, Hanada N. Nomura Y, et al. Among authors: yabuki y. J Oral Sci. 2019 Nov 27;61(4):544-548. doi: 10.2334/josnusd.18-0288. Epub 2019 Sep 20. J Oral Sci. 2019. PMID: 31548452 Free article.
Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study.
Ueda E, Toya Y, Wakui H, Ishiga K, Kawai Y, Kobayashi R, Kinguchi S, Kanaoka T, Saigusa Y, Mikami T, Yabuki Y, Goda M, Machida D, Fujita T, Haruhara K, Sugano T, Azushima K, Tamura K. Ueda E, et al. Among authors: yabuki y. J Atheroscler Thromb. 2024 Apr 3. doi: 10.5551/jat.64639. Online ahead of print. J Atheroscler Thromb. 2024. PMID: 38569869 Free article.
Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.
Kozai H, Ogino H, Mitsuhashi A, Nguyen NT, Tsukazaki Y, Yabuki Y, Ozaki R, Yoneda H, Sato S, Hanibuchi M, Shinohara T, Nokihara H, Nishioka Y. Kozai H, et al. Among authors: yabuki y. Thorac Cancer. 2024 Feb;15(5):369-378. doi: 10.1111/1759-7714.15200. Epub 2023 Dec 26. Thorac Cancer. 2024. PMID: 38146645 Free PMC article.
A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer.
Yabuki Y, Hanibuchi M, Takeuchi E, Haku T, Kanematsu T, Nishimura N, Toyoda Y, Mitsuhashi A, Otsuka K, Sato S, Goto H, Yoneda H, Ogino H, Nokihara H, Tsutomu S, Nishioka Y. Yabuki Y, et al. Thorac Cancer. 2023 Nov;14(32):3232-3239. doi: 10.1111/1759-7714.15115. Epub 2023 Sep 17. Thorac Cancer. 2023. PMID: 37718463 Free PMC article. Clinical Trial.
FoundationOne CDx detected an uncovered variant of epidermal growth factor receptor exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma.
Takahashi H, Ogino H, Bando H, Mitsuhashi A, Tsukazaki Y, Yabuki Y, Ozaki R, Yoneda H, Sato S, Hanibuchi M, Nishioka Y. Takahashi H, et al. Among authors: yabuki y. Respir Med Case Rep. 2023 Jul 7;45:101893. doi: 10.1016/j.rmcr.2023.101893. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37485237 Free PMC article.
206 results